Camas, Katherine P.

HRN: 22-97-22  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2023
CEFUROXIME 1.5GM (VIAL)
05/29/2023
05/31/2023
IVTT
1.5g
Q8 X 3 Doses
Sp Tabhso
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: